During the past decade, Peterfy Sandor utcai Korhaz-Rendelointezet es Baleseti Kozpont, Szemeszet KR conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 12 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Peterfy Sandor utcai Korhaz-Rendelointezet es Baleseti Kozpont, Szemeszet KR" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Pfizer" with 4 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Péterfy Sándor Hospital" with 2 trials sponsored and "AstraZeneca" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Peterfy Sandor utcai Korhaz-Rendelointezet es Baleseti Kozpont, Szemeszet KR" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator and "Szeged University" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Peterfy Sandor utcai Korhaz-Rendelointezet es Baleseti Kozpont, Szemeszet KR" are "Crohn's Disease" (4 trials), "Geographic Atrophy" (3 trials), "Diabetes Mellitus, Type 2" (2 trials), "Diabetic Macular Edema" (2 trials) and "Acute Ischemic Stroke" (1 trials). Many other conditions were trialed in "Peterfy Sandor utcai Korhaz-Rendelointezet es Baleseti Kozpont, Szemeszet KR" in a lesser frequency.

Most popular intervention types in "Peterfy Sandor utcai Korhaz-Rendelointezet es Baleseti Kozpont, Szemeszet KR" are "Drug" (22 trials), "Other" (5 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "CP-690,550" (4 trials), "Faricimab" (2 trials), "Guselkumab Dose 1" (2 trials) and "Guselkumab Dose 2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Peterfy Sandor utcai Korhaz-Rendelointezet es Baleseti Kozpont, Szemeszet KR" are 25 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Peterfy Sandor utcai Korhaz-Rendelointezet es Baleseti Kozpont, Szemeszet KR". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Peterfy Sandor utcai Korhaz-Rendelointezet es Baleseti Kozpont, Szemeszet KR, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Peterfy Sandor utcai Korhaz-Rendelointezet es Baleseti Kozpont, Szemeszet KR, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".